INCY vs TXO · P/E 14, rev $5.14B vs rev $401.0M
Incyte Corporation (INCY) versus MorningStar Partners, L.P. (TXO) — a side-by-side from cached financials, not a winner call.
Incyte Corporation (INCY) is a biotechnology company listed on US.
MorningStar Partners, L.P. (TXO) is a oil & gas e&p company listed on NYSE.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. Revenue was up 21.2% from 2024-12-31 to 2025-12-31. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Latest reported TXO revenue for 2025-12-31 was $401.0M. Net income was -$21.6M. Revenue was up 41.8% from 2024-12-31 to 2025-12-31. TXO currently screens at market cap $693.8M.
INCY currently screens at market cap $20.45B and trailing P/E 14.5. TXO currently screens at market cap $693.8M.
Not investment advice. Open the INCY and TXO stock pages for the full models.
Not investment advice.